GOOD NEWS!!! - /humps desk

Exubera® is approved in both the U.S. and the EU for adults with type 1 and type 2 diabetes. Nektar developed the inhaler and the powder insulin formulation for Exubera®. Our partner, Pfizer, will be responsible for marketing and promoting Exubera® worldwide.
Exubera® is a rapid-acting, dry powder human insulin that is inhaled through the mouth into the lungs prior to eating, using the handheld Exubera® Inhaler. The Exubera® Inhaler weighs four ounces and, when closed, is about the size of an eyeglass case. The unique Exubera® Inhaler produces a cloud of insulin powder in a clear chamber visible to the patient. This insulin powder is designed to pass rapidly into the bloodstream to regulate the body’s blood sugar levels.
Exubera® is a result of an innovative partnership between Nektar Therapeutics and Pfizer Inc. We pioneered the product and developed the core technologies used for Exubera,® including the formulation and particle engineering for the insulin powder, the filling and packaging techniques for the insulin blister, and the Exubera® Inhaler with its components. Pfizer manufactures and sells Exubera.® Nektar supports manufacturing including powder processing for Exubera® insulin, and manufactures the Exubera® Inhalers.
As part of our agreement with Pfizer, Nektar receives royalties on sales of Exubera® by Pfizer and revenue for the manufacture of the insulin powder and the Exubera® Inhalers.
The burden of diabetes in the U.S. and Europe Nearly 21 million Americans and 48 million Europeans have diabetes.(*) Despite existing therapies for diabetes, millions of patients don’t achieve or maintain acceptable blood sugar levels. Complications from uncontrolled or poorly controlled blood sugar levels in diabetes patients can include heart disease, amputation, blindness and kidney failure.
In type 2 diabetes, which represents 95 percent of patients, the body does not make or use insulin well enough to manage blood sugar levels. Type 2 diabetes progresses over time, and eventually most patients will need to administer insulin to achieve blood sugar control. In type 1 diabetes, the body does not make insulin at all. These patients must take insulin to survive.

...